Page Content
The Intermountain Bone Marrow Transplantation program at LDS Hospital is currently involved in several research protocols, including:
A Multicenter, Phase III Study Comparing Non-myeloablative Conditioning with TBI versus Fludarabine/TBI for HLA-Matched Related Hematopoietic Cell Transplantation for Treatment of Hematologic Malignancies
A Multi Center Study of Non-myeloablative Conditioning with TBI or Fludarabine/TBI for HLA-matched Related Hematopoietic Cell Transplantation for Treatment of Hematologic Malignancies with Post Grafting Immunosuppression with Tacrolimus and MMF
A Randomized Phase II Study to Determine the Most Promising Postgrafting Immunosuppression for Prevention of Acute GVHD after Unrelated Donor G-CSF mobilized Peripheral Blood Mononuclear Cell Transplantation using Non-myeloablative Conditioning for Patients with Hematologic Malignancies: A Multicenter Trial
AN NMDP Research Database for Allogeneic Unrelated Hematopoietic Stem Cell Transplantation